Healthcare provider profile · identity verified

Mitchell Cohen, M.D.

Internal Medicine · NASHUA, NH · NPI 1972589208

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	496	159
Atorvastatin Calcium	Atorvastatin Calcium	324	109
Amlodipine Besylate	Amlodipine Besylate	263	85
Lisinopril	Lisinopril	236	76
Gabapentin	Gabapentin	234	53
Levothyroxine Sodium	Levothyroxine Sodium	207	70
Clonazepam	Clonazepam	192	29
Hydrochlorothiazide	Hydrochlorothiazide	190	61
Losartan Potassium	Losartan Potassium	169	51
Duloxetine Hcl	Duloxetine Hcl	165	46
Buprenorphine Hcl	Buprenorphine Hcl	153	20
Metformin Hcl Er	Metformin Hcl	141	44
Metoprolol Succinate	Metoprolol Succinate	132	42
Pantoprazole Sodium	Pantoprazole Sodium	132	42
Omeprazole	Omeprazole	131	41
Eliquis	Apixaban	124	30
Sertraline Hcl	Sertraline Hcl	124	40
Albuterol Sulfate Hfa	Albuterol Sulfate	123	43
Alprazolam	Alprazolam	123	26
Metformin Hcl	Metformin Hcl	122	38
Ezetimibe	Ezetimibe	121	37
Oxycodone Hcl	Oxycodone Hcl	121	27
Pravastatin Sodium	Pravastatin Sodium	115	39
Zolpidem Tartrate	Zolpidem Tartrate	112	26
Bisoprolol Fumarate	Bisoprolol Fumarate	105	35
Topiramate	Topiramate	98	28
Tamsulosin Hcl	Tamsulosin Hcl	88	25
Escitalopram Oxalate	Escitalopram Oxalate	81	24
Lorazepam	Lorazepam	81	21
Metoprolol Tartrate	Metoprolol Tartrate	79	28
Jardiance	Empagliflozin	74	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	13
Bupropion Xl	Bupropion Hcl	69	22
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	68	14
Prednisone	Prednisone	68	21
Spironolactone	Spironolactone	64	22
Tramadol Hcl	Tramadol Hcl	64	16
Allopurinol	Allopurinol	63	22
Famotidine	Famotidine	61	21
Irbesartan	Irbesartan	59	19
Simvastatin	Simvastatin	56	19
Furosemide	Furosemide	55	22
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Telmisartan	Telmisartan	55	17
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	54	20
Trazodone Hcl	Trazodone Hcl	53	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Celecoxib	Celecoxib	50	17
Rybelsus	Semaglutide	50	suppressed
Potassium Chloride	Potassium Chloride	49	18
Clonidine Hcl	Clonidine Hcl	45	11
Mirtazapine	Mirtazapine	45	13
Montelukast Sodium	Montelukast Sodium	45	14
Fluticasone Propionate	Fluticasone Propionate	44	12
Finasteride	Finasteride	43	13
Meloxicam	Meloxicam	43	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	40	suppressed
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Promethazine Hcl	Promethazine Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Valsartan	Valsartan	38	13
Diazepam	Diazepam	37	suppressed
Valacyclovir	Valacyclovir Hcl	36	15
Atenolol	Atenolol	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Myrbetriq	Mirabegron	32	suppressed
Glimepiride	Glimepiride	31	suppressed
Ozempic	Semaglutide	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Temazepam	Temazepam	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Mounjaro	Tirzepatide	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Testosterone	Testosterone	28	suppressed
Olanzapine	Olanzapine	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	11
Nystatin	Nystatin	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Glipizide	Glipizide	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Methadone Hcl	Methadone Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Pregabalin	Pregabalin	22	suppressed
Minoxidil	Minoxidil	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Torsemide	Torsemide	17	suppressed
Baclofen	Baclofen	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Estradiol	Estradiol	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Oxazepam	Oxazepam	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Gemtesa	Vibegron	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Risperidone	Risperidone	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error